speb/financial-data huggingface dataset:
CGNX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CGNX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CGNX income_statement (annual, 2025-12-31) — Pretax Income: 182802000.00
CGNX income_statement (quarterly, 2025-12-31) — Pretax Income: 44079000.00
CGNX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -445000.00
CGNX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1707000.00
CGNX balance_sheet (annual, 2025-12-31) — Properties: 0.00
CGNX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CGNX cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CGNX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CGNX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -290224000.00
CGNX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -40753000.00
CGNX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -8743000.00
CGNX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2596000.00
CGNX balance_sheet (annual, 2025-12-31) — Raw Materials: 75417000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 75417000.00
CGNX balance_sheet (annual, 2025-12-31) — Receivables: 163693000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Receivables: 163693000.00
CGNX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 328966000.00
CGNX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 86434000.00
CGNX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 30793000.00
CGNX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7327000.00
CGNX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -151233000.00
CGNX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -25000000.00
CGNX income_statement (annual, 2025-12-31) — Research And Development: 138970000.00
CGNX income_statement (quarterly, 2025-12-31) — Research And Development: 36060000.00
CGNX balance_sheet (annual, 2025-12-31) — Retained Earnings: 406355000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 406355000.00
CGNX cash_flow (annual, 2025-12-31) — Sale Of Investment: 320279000.00
CGNX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 17037000.00
CGNX cash_flow (annual, 2025-12-31) — Sale Of PPE: 6704000.00
CGNX income_statement (annual, 2025-12-31) — Selling General And Administration: 363857000.00
CGNX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 94568000.00
CGNX balance_sheet (annual, 2025-12-31) — Share Issued: 166997000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Share Issued: 166997000.00
CGNX income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CGNX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 48517000.00
CGNX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 13868000.00
CGNX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1491901000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1491901000.00
CGNX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1024522000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1024522000.00
CGNX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 4812072.52
CGNX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 972938.47
CGNX income_statement (annual, 2025-12-31) — Tax Provision: 68360000.00
CGNX income_statement (quarterly, 2025-12-31) — Tax Provision: 11415000.00
CGNX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.37
CGNX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
CGNX balance_sheet (annual, 2025-12-31) — Total Assets: 2016555000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Assets: 2016555000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Capitalization: 1491901000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1491901000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Debt: 76586000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Debt: 76586000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1491901000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1491901000.00
CGNX income_statement (annual, 2025-12-31) — Total Expenses: 831793000.00
CGNX income_statement (quarterly, 2025-12-31) — Total Expenses: 217062000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 524654000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 524654000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1319309000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1319309000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 341103000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 341103000.00
CGNX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 162566000.00
CGNX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 35276000.00
CGNX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 9141000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 9141000.00
CGNX income_statement (annual, 2025-12-31) — Total Unusual Items: 12868000.00
CGNX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 3757000.00
CGNX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 12868000.00
CGNX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3757000.00
CGNX balance_sheet (annual, 2025-12-31) — Work In Process: 4877000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Work In Process: 4877000.00
CGNX balance_sheet (annual, 2025-12-31) — Working Capital: 513695000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Working Capital: 513695000.00
CGNX income_statement (quarterly, 2026-03-31) — +Operating Expense: 131066000.00
CGNX income_statement (quarterly, 2026-03-31) — +Total Revenue: 268437000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 59551000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 170721000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1194927000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -781000.00
CGNX cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 2532000.00
CGNX cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 2532000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3825000.00
CGNX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 166514000.00
CGNX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.31
CGNX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 262925000.00
CGNX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2757000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 74017000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 333000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 237343000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 296756000.00
CGNX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -14196000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 59152000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 178191000.00
CGNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -68901000.00
CGNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 791000.00
CGNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 45093000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 9390000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -13554000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -2905000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Inventory: 8000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 10349000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Payable: 6485000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -7069000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -12212000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -23118000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -2905000.00
CGNX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -32042000.00
CGNX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -23711000.00
CGNX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -23017000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Common Stock: 333000.00
CGNX cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -14196000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1478969000.00
CGNX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -98995000.00
CGNX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 77498000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 77399000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Assets: 690349000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12310000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12310000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 34053000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 34053000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 189485000.00
CGNX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 4740000.00
CGNX cash_flow (quarterly, 2026-03-31) — Deferred Tax: 4740000.00
CGNX cash_flow (quarterly, 2026-03-31) — Depreciation: 4703000.00
CGNX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7235000.00
CGNX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7235000.00
CGNX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 168386000.00
CGNX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.31
CGNX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — EBIT: 59873000.00
CGNX income_statement (quarterly, 2026-03-31) — EBITDA: 67108000.00
CGNX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2565000.00
CGNX cash_flow (quarterly, 2026-03-31) — End Cash Position: 237343000.00
CGNX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -68901000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 59207000.00
CGNX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 42336000.00
CGNX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 1539000.00
CGNX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3491000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -60734000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Goodwill: 382818000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 449958000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 171502000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 154000000.00
CGNX income_statement (quarterly, 2026-03-31) — Gross Profit: 190939000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 321361000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 6172000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Inventory: 135549000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1478969000.00
CGNX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 791000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 325186000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 325186000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 61707000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 61707000.00
CGNX cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 11519000.00
CGNX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -98995000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 51704000.00
CGNX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 51704000.00
CGNX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 51704000.00
CGNX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -7971000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Net PPE: 154000000.00
CGNX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2757000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1029011000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 381100000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 273566000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 381100000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 273566000.00
CGNX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 63617000.00
CGNX income_statement (quarterly, 2026-03-31) — Normalized Income: 48781276.03
CGNX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 45093000.00
CGNX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1539000.00
CGNX income_statement (quarterly, 2026-03-31) — Operating Income: 59873000.00
CGNX income_statement (quarterly, 2026-03-31) — Operating Revenue: 268437000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 166527000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 70922000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -60734000.00
CGNX income_statement (quarterly, 2026-03-31) — Other Income Expense: 1884000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 67140000.00
CGNX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -16000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 5025000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1891000.00
CGNX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1607000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Properties: 154000000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 16401000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 59413000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Payables: 65723000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 143122000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CGNX income_statement (quarterly, 2026-03-31) — Pretax Income: 61757000.00
CGNX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 44290000.00
CGNX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -47013000.00
CGNX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2757000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Raw Materials: 69896000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Receivables: 187122000.00
CGNX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 77498000.00
CGNX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7235000.00
CGNX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -98995000.00
CGNX income_statement (quarterly, 2026-03-31) — Research And Development: 37025000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 344443000.00
CGNX cash_flow (quarterly, 2026-03-31) — Sale Of Business: 11519000.00
CGNX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 39042000.00
CGNX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 94041000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Share Issued: 166527000.00
CGNX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 11933000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1478969000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1029011000.00
CGNX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 568276.03
CGNX income_statement (quarterly, 2026-03-31) — Tax Provision: 10053000.00
CGNX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.16
CGNX balance_sheet (quarterly, 2026-03-31) — Total Assets: 2005618000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1478969000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Debt: 74017000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1478969000.00
CGNX income_statement (quarterly, 2026-03-31) — Total Expenses: 208564000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 526649000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1315269000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 337164000.00
CGNX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 59873000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6172000.00
CGNX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 3491000.00
CGNX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 3491000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Work In Process: 6446000.00
CGNX balance_sheet (quarterly, 2026-03-31) — Working Capital: 500864000.00
CGO balance_sheet (annual, 2021-10-31) — Available For Sale Securities: 207972898.00
CGO cash_flow (annual, 2021-10-31) — Common Stock Issuance: 7433922.00
CGO balance_sheet (annual, 2021-10-31) — Derivative Product Liabilities: 788497.00
CGO cash_flow (annual, 2021-10-31) — Issuance Of Capital Stock: 12444150.00
CGO cash_flow (annual, 2021-10-31) — Issuance Of Debt: 13500000.00
CGO cash_flow (annual, 2021-10-31) — Long Term Debt Issuance: 13500000.00
CGO cash_flow (annual, 2021-10-31) — Net Common Stock Issuance: 7433922.00
CGO cash_flow (annual, 2021-10-31) — Preferred Stock Issuance: 5010228.00
CGO income_statement (annual, 2022-10-31) — +Operating Expense: 562374.00
CGO income_statement (annual, 2022-10-31) — +Total Revenue: -47894755.00
CGO balance_sheet (annual, 2022-10-31) — Accounts Payable: 1215387.00
CGO income_statement (annual, 2022-10-31) — Basic Average Shares: 9538805.00
CGO income_statement (annual, 2022-10-31) — Basic EPS: -5.08
CGO cash_flow (annual, 2022-10-31) — Beginning Cash Position: 4573392.00
CGO balance_sheet (annual, 2022-10-31) — Capital Stock: 117810923.00
CGO balance_sheet (annual, 2022-10-31) — Cash And Cash Equivalents: 1040.00
CGO balance_sheet (annual, 2022-10-31) — Cash Cash Equivalents And Federal Funds Sold: 5057146.00
CGO cash_flow (annual, 2022-10-31) — Cash Dividends Paid: -10989283.00
CGO balance_sheet (annual, 2022-10-31) — Cash Financial: 1040.00
CGO cash_flow (annual, 2022-10-31) — Change In Other Current Assets: 13898.00
CGO cash_flow (annual, 2022-10-31) — Change In Other Current Liabilities: 0.00
CGO cash_flow (annual, 2022-10-31) — Change In Payable: -75405.00
CGO cash_flow (annual, 2022-10-31) — Change In Prepaid Assets: 1829.00
CGO cash_flow (annual, 2022-10-31) — Change In Receivables: -29858.00
CGO cash_flow (annual, 2022-10-31) — Change In Working Capital: -89536.00
CGO cash_flow (annual, 2022-10-31) — Changes In Cash: 483754.00
CGO balance_sheet (annual, 2022-10-31) — Common Stock: 117810923.00
CGO cash_flow (annual, 2022-10-31) — Common Stock Dividend Paid: -10989283.00
CGO balance_sheet (annual, 2022-10-31) — Common Stock Equity: 94185621.00
CGO cash_flow (annual, 2022-10-31) — Common Stock Issuance: 4935247.00
CGO income_statement (annual, 2022-10-31) — Diluted Average Shares: 9538805.00
CGO income_statement (annual, 2022-10-31) — Diluted EPS: -5.08
CGO income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: -48457129.00
CGO cash_flow (annual, 2022-10-31) — End Cash Position: 5057146.00
CGO balance_sheet (annual, 2022-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 129795323.00
CGO cash_flow (annual, 2022-10-31) — Financing Cash Flow: -30665480.00
CGO cash_flow (annual, 2022-10-31) — Free Cash Flow: 31149234.00
CGO cash_flow (annual, 2022-10-31) — Gain Loss On Investment Securities: 78323308.00
CGO income_statement (annual, 2022-10-31) — Gain On Sale Of Security: 2822498.00
CGO income_statement (annual, 2022-10-31) — General And Administrative Expense: 335648.00
CGO income_statement (annual, 2022-10-31) — Interest Expense: 1226102.00
CGO income_statement (annual, 2022-10-31) — Interest Income: 1378590.00
CGO balance_sheet (annual, 2022-10-31) — Invested Capital: 120185621.00
CGO balance_sheet (annual, 2022-10-31) — Investmentin Financial Assets: 131062463.00
CGO balance_sheet (annual, 2022-10-31) — Investments And Advances: 131062463.00
CGO cash_flow (annual, 2022-10-31) — Issuance Of Capital Stock: 4935247.00
CGO balance_sheet (annual, 2022-10-31) — Long Term Debt And Capital Lease Obligation: 26000000.00
CGO cash_flow (annual, 2022-10-31) — Long Term Debt Payments: -24500000.00
CGO cash_flow (annual, 2022-10-31) — Net Common Stock Issuance: 4935247.00
CGO balance_sheet (annual, 2022-10-31) — Net Debt: 25998960.00
CGO cash_flow (annual, 2022-10-31) — Net Foreign Currency Exchange Gain Loss: -14232.00
CGO income_statement (annual, 2022-10-31) — Net Income: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Income Common Stockholders: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Income Continuous Operations: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: -48457129.00
CGO cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: -48457129.00
CGO income_statement (annual, 2022-10-31) — Net Interest Income: 152488.00
CGO cash_flow (annual, 2022-10-31) — Net Issuance Payments Of Debt: -24500000.00
CGO cash_flow (annual, 2022-10-31) — Net Long Term Debt Issuance: -24500000.00
CGO cash_flow (annual, 2022-10-31) — Net Other Financing Charges: 0.00
CGO cash_flow (annual, 2022-10-31) — Net Preferred Stock Issuance: -1151.00
CGO balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 94185621.00
CGO income_statement (annual, 2022-10-31) — Normalized Income: -48457129.00
CGO cash_flow (annual, 2022-10-31) — Operating Cash Flow: 31149234.00
CGO income_statement (annual, 2022-10-31) — Operating Revenue: -47894755.00
CGO balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 9823566.00
CGO cash_flow (annual, 2022-10-31) — Other Non Cash Items: 1386823.00
CGO income_statement (annual, 2022-10-31) — Other Operating Expenses: 226726.00
CGO balance_sheet (annual, 2022-10-31) — Other Payable: 377378.00
CGO balance_sheet (annual, 2022-10-31) — Payables: 1592765.00
CGO balance_sheet (annual, 2022-10-31) — Preferred Securities Outside Stock Equity: 16857599.00
CGO cash_flow (annual, 2022-10-31) — Preferred Stock Payments: -1151.00
CGO balance_sheet (annual, 2022-10-31) — Prepaid Assets: 59404.00
CGO income_statement (annual, 2022-10-31) — Pretax Income: -48457129.00
CGO balance_sheet (annual, 2022-10-31) — Receivables: 2456972.00
CGO cash_flow (annual, 2022-10-31) — Repayment Of Debt: -24500000.00
CGO cash_flow (annual, 2022-10-31) — Repurchase Of Capital Stock: -1151.00
CGO balance_sheet (annual, 2022-10-31) — Retained Earnings: -23625302.00
CGO income_statement (annual, 2022-10-31) — Selling General And Administration: 335648.00
CGO balance_sheet (annual, 2022-10-31) — Share Issued: 9823566.00
CGO balance_sheet (annual, 2022-10-31) — Stockholders Equity: 94185621.00
CGO balance_sheet (annual, 2022-10-31) — Tangible Book Value: 94185621.00
CGO income_statement (annual, 2022-10-31) — Tax Effect Of Unusual Items: 0.00
CGO income_statement (annual, 2022-10-31) — Tax Rate For Calcs: 0.00
CGO balance_sheet (annual, 2022-10-31) — Total Assets: 138684033.00
CGO balance_sheet (annual, 2022-10-31) — Total Capitalization: 120185621.00
CGO balance_sheet (annual, 2022-10-31) — Total Debt: 26000000.00
CGO balance_sheet (annual, 2022-10-31) — Total Equity Gross Minority Interest: 94185621.00
CGO balance_sheet (annual, 2022-10-31) — Total Liabilities Net Minority Interest: 44498412.00
CGO income_statement (annual, 2023-10-31) — +Operating Expense: 480914.00
CGO income_statement (annual, 2023-10-31) — +Total Revenue: 5283436.00
CGO balance_sheet (annual, 2023-10-31) — Accounts Payable: 820805.00
CGO income_statement (annual, 2023-10-31) — Basic Average Shares: 9801065.00
CGO income_statement (annual, 2023-10-31) — Basic EPS: 0.49
CGO cash_flow (annual, 2023-10-31) — Beginning Cash Position: 5057146.00
CGO balance_sheet (annual, 2023-10-31) — Capital Stock: 114926525.00
CGO balance_sheet (annual, 2023-10-31) — Cash And Cash Equivalents: 120.00
CGO balance_sheet (annual, 2023-10-31) — Cash Cash Equivalents And Federal Funds Sold: 4431756.00
CGO cash_flow (annual, 2023-10-31) — Cash Dividends Paid: -9408948.00
CGO balance_sheet (annual, 2023-10-31) — Cash Financial: 120.00
CGO cash_flow (annual, 2023-10-31) — Change In Other Current Assets: -820.00
CGO cash_flow (annual, 2023-10-31) — Change In Other Current Liabilities: 0.00
CGO cash_flow (annual, 2023-10-31) — Change In Payable: 81611.00
CGO cash_flow (annual, 2023-10-31) — Change In Prepaid Assets: 1724.00
CGO cash_flow (annual, 2023-10-31) — Change In Receivables: -1889.00
CGO cash_flow (annual, 2023-10-31) — Change In Working Capital: 80626.00
CGO cash_flow (annual, 2023-10-31) — Changes In Cash: -625390.00
CGO balance_sheet (annual, 2023-10-31) — Common Stock: 114926525.00
CGO cash_flow (annual, 2023-10-31) — Common Stock Dividend Paid: -9408948.00
CGO balance_sheet (annual, 2023-10-31) — Common Stock Equity: 89579195.00
CGO balance_sheet (annual, 2023-10-31) — Derivative Product Liabilities: 36365.00
CGO income_statement (annual, 2023-10-31) — Diluted Average Shares: 9801065.00
CGO income_statement (annual, 2023-10-31) — Diluted EPS: 0.49
CGO income_statement (annual, 2023-10-31) — Diluted NI Availto Com Stockholders: 4802522.00
CGO cash_flow (annual, 2023-10-31) — End Cash Position: 4431756.00
CGO balance_sheet (annual, 2023-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 132425055.00
CGO cash_flow (annual, 2023-10-31) — Financing Cash Flow: -5353113.00
CGO cash_flow (annual, 2023-10-31) — Free Cash Flow: 4727723.00
CGO cash_flow (annual, 2023-10-31) — Gain Loss On Investment Securities: -1427576.00
CGO income_statement (annual, 2023-10-31) — Gain On Sale Of Security: 7447343.00
CGO income_statement (annual, 2023-10-31) — General And Administrative Expense: 349218.00
CGO income_statement (annual, 2023-10-31) — Interest Expense: 2011391.00
CGO income_statement (annual, 2023-10-31) — Interest Income: 1726703.00
CGO balance_sheet (annual, 2023-10-31) — Invested Capital: 119679195.00
CGO balance_sheet (annual, 2023-10-31) — Investmentin Financial Assets: 132749523.00
CGO balance_sheet (annual, 2023-10-31) — Investments And Advances: 132749523.00
CGO cash_flow (annual, 2023-10-31) — Issuance Of Debt: 13600000.00
CGO balance_sheet (annual, 2023-10-31) — Long Term Debt And Capital Lease Obligation: 30100000.00
CGO cash_flow (annual, 2023-10-31) — Long Term Debt Issuance: 13600000.00
CGO cash_flow (annual, 2023-10-31) — Long Term Debt Payments: -9500000.00
CGO balance_sheet (annual, 2023-10-31) — Net Debt: 30099880.00
CGO income_statement (annual, 2023-10-31) — Net Income: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Income Common Stockholders: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Income Continuous Operations: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Income From Continuing And Discontinued Operation: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Income From Continuing Operation Net Minority Interest: 4802522.00
CGO cash_flow (annual, 2023-10-31) — Net Income From Continuing Operations: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Income Including Noncontrolling Interests: 4802522.00
CGO income_statement (annual, 2023-10-31) — Net Interest Income: -284688.00
CGO cash_flow (annual, 2023-10-31) — Net Issuance Payments Of Debt: 4100000.00
CGO cash_flow (annual, 2023-10-31) — Net Long Term Debt Issuance: 4100000.00
CGO cash_flow (annual, 2023-10-31) — Net Other Financing Charges: 0.00
CGO cash_flow (annual, 2023-10-31) — Net Preferred Stock Issuance: 114.00
CGO balance_sheet (annual, 2023-10-31) — Net Tangible Assets: 89579195.00
CGO income_statement (annual, 2023-10-31) — Normalized Income: 4802522.00
CGO cash_flow (annual, 2023-10-31) — Operating Cash Flow: 4727723.00
CGO income_statement (annual, 2023-10-31) — Operating Revenue: 5283436.00
CGO balance_sheet (annual, 2023-10-31) — Ordinary Shares Number: 9825838.00
CGO cash_flow (annual, 2023-10-31) — Other Non Cash Items: 1272151.00
CGO income_statement (annual, 2023-10-31) — Other Operating Expenses: 131696.00
CGO balance_sheet (annual, 2023-10-31) — Other Payable: 458169.00
CGO balance_sheet (annual, 2023-10-31) — Payables: 1278974.00
CGO balance_sheet (annual, 2023-10-31) — Preferred Securities Outside Stock Equity: 16894595.00
CGO cash_flow (annual, 2023-10-31) — Preferred Stock Payments: 114.00
CGO balance_sheet (annual, 2023-10-31) — Prepaid Assets: 57680.00
CGO income_statement (annual, 2023-10-31) — Pretax Income: 4802522.00
CGO balance_sheet (annual, 2023-10-31) — Receivables: 650170.00
CGO cash_flow (annual, 2023-10-31) — Repayment Of Debt: -9500000.00
CGO cash_flow (annual, 2023-10-31) — Repurchase Of Capital Stock: 114.00
CGO balance_sheet (annual, 2023-10-31) — Retained Earnings: -25347330.00
CGO income_statement (annual, 2023-10-31) — Selling General And Administration: 349218.00
CGO balance_sheet (annual, 2023-10-31) — Share Issued: 9825838.00
CGO balance_sheet (annual, 2023-10-31) — Stockholders Equity: 89579195.00
CGO balance_sheet (annual, 2023-10-31) — Tangible Book Value: 89579195.00
CGO income_statement (annual, 2023-10-31) — Tax Effect Of Unusual Items: 0.00
CGO income_statement (annual, 2023-10-31) — Tax Rate For Calcs: 0.21
CGO balance_sheet (annual, 2023-10-31) — Total Assets: 137937997.00
CGO balance_sheet (annual, 2023-10-31) — Total Capitalization: 119679195.00
CGO balance_sheet (annual, 2023-10-31) — Total Debt: 30100000.00
CGO balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 89579195.00
CGO balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 48358802.00
CGO income_statement (annual, 2024-10-31) — +Operating Expense: 393551.00
CGO income_statement (annual, 2024-10-31) — +Total Revenue: 36144636.00
CGO balance_sheet (annual, 2024-10-31) — Accounts Payable: 938369.00
CGO balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 938369.00
CGO income_statement (annual, 2024-10-31) — Basic Average Shares: 9821727.00
CGO income_statement (annual, 2024-10-31) — Basic EPS: 3.64
CGO cash_flow (annual, 2024-10-31) — Beginning Cash Position: 4431756.00
CGO balance_sheet (annual, 2024-10-31) — Capital Stock: 114769615.00
CGO balance_sheet (quarterly, 2024-10-31) — Capital Stock: 114769615.00
CGO balance_sheet (annual, 2024-10-31) — Cash And Cash Equivalents: 18.00
CGO balance_sheet (quarterly, 2024-10-31) — Cash And Cash Equivalents: 18.00
CGO balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 6854402.00
CGO balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 6854402.00
CGO cash_flow (annual, 2024-10-31) — Cash Dividends Paid: -9415085.00
CGO balance_sheet (annual, 2024-10-31) — Cash Financial: 18.00
CGO balance_sheet (quarterly, 2024-10-31) — Cash Financial: 18.00
CGO cash_flow (annual, 2024-10-31) — Change In Other Current Assets: -17633.00
CGO cash_flow (annual, 2024-10-31) — Change In Other Current Liabilities: 0.00
CGO cash_flow (annual, 2024-10-31) — Change In Payable: 96096.00
CGO cash_flow (annual, 2024-10-31) — Change In Prepaid Assets: 14917.00
CGO cash_flow (annual, 2024-10-31) — Change In Receivables: -83309.00
CGO cash_flow (annual, 2024-10-31) — Change In Working Capital: 10071.00
CGO cash_flow (annual, 2024-10-31) — Changes In Cash: 2422646.00
CGO balance_sheet (annual, 2024-10-31) — Common Stock: 114769615.00
CGO balance_sheet (quarterly, 2024-10-31) — Common Stock: 114769615.00
CGO cash_flow (annual, 2024-10-31) — Common Stock Dividend Paid: -9415085.00
CGO balance_sheet (annual, 2024-10-31) — Common Stock Equity: 115917155.00
CGO balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 115917155.00
CGO balance_sheet (annual, 2024-10-31) — Derivative Product Liabilities: 19084.00
CGO balance_sheet (quarterly, 2024-10-31) — Derivative Product Liabilities: 19084.00
CGO income_statement (annual, 2024-10-31) — Diluted Average Shares: 9821727.00
CGO income_statement (annual, 2024-10-31) — Diluted EPS: 3.64
CGO income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 35751085.00
CGO cash_flow (annual, 2024-10-31) — End Cash Position: 6854402.00
CGO balance_sheet (annual, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 169690726.00
CGO balance_sheet (quarterly, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 169690726.00
CGO cash_flow (annual, 2024-10-31) — Financing Cash Flow: 5227441.00
CGO cash_flow (annual, 2024-10-31) — Free Cash Flow: -2804795.00
CGO cash_flow (annual, 2024-10-31) — Gain Loss On Investment Securities: -40125496.00
CGO income_statement (annual, 2024-10-31) — Gain On Sale Of Security: 13157460.00
CGO income_statement (annual, 2024-10-31) — General And Administrative Expense: 217067.00
CGO income_statement (annual, 2024-10-31) — Interest Expense: 2803950.00
CGO income_statement (annual, 2024-10-31) — Interest Income: 2559786.00
CGO balance_sheet (annual, 2024-10-31) — Invested Capital: 164717155.00
CGO balance_sheet (quarterly, 2024-10-31) — Invested Capital: 164717155.00
CGO balance_sheet (annual, 2024-10-31) — Investmentin Financial Assets: 171043168.00
CGO balance_sheet (quarterly, 2024-10-31) — Investmentin Financial Assets: 171043168.00
CGO balance_sheet (annual, 2024-10-31) — Investments And Advances: 171043168.00
CGO balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 171043168.00
CGO cash_flow (annual, 2024-10-31) — Issuance Of Debt: 18700000.00
CGO balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 48800000.00
CGO balance_sheet (quarterly, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 48800000.00
CGO cash_flow (annual, 2024-10-31) — Long Term Debt Issuance: 18700000.00
CGO balance_sheet (annual, 2024-10-31) — Net Debt: 48799982.00
CGO balance_sheet (quarterly, 2024-10-31) — Net Debt: 48799982.00
CGO income_statement (annual, 2024-10-31) — Net Income: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 35751085.00
CGO cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 35751085.00
CGO income_statement (annual, 2024-10-31) — Net Interest Income: -244164.00
CGO cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: 18700000.00
CGO cash_flow (annual, 2024-10-31) — Net Long Term Debt Issuance: 18700000.00
CGO cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 0.00
CGO cash_flow (annual, 2024-10-31) — Net Preferred Stock Issuance: -4013334.00
CGO balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 115917155.00
CGO balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 115917155.00
CGO income_statement (annual, 2024-10-31) — Normalized Income: 35751085.00
CGO cash_flow (annual, 2024-10-31) — Operating Cash Flow: -2804795.00
CGO income_statement (annual, 2024-10-31) — Operating Revenue: 36144636.00
CGO balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 9827294.00
CGO balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 9827294.00
CGO cash_flow (annual, 2024-10-31) — Other Non Cash Items: 1559545.00
CGO income_statement (annual, 2024-10-31) — Other Operating Expenses: 176484.00
CGO balance_sheet (annual, 2024-10-31) — Other Payable: 801929.00
CGO balance_sheet (quarterly, 2024-10-31) — Other Payable: 801929.00
CGO balance_sheet (annual, 2024-10-31) — Payables: 1740298.00
CGO balance_sheet (quarterly, 2024-10-31) — Payables: 1740298.00
CGO balance_sheet (annual, 2024-10-31) — Preferred Securities Outside Stock Equity: 12930728.00
CGO balance_sheet (quarterly, 2024-10-31) — Preferred Securities Outside Stock Equity: 12930728.00
CGO cash_flow (annual, 2024-10-31) — Preferred Stock Payments: -4013334.00
CGO balance_sheet (annual, 2024-10-31) — Prepaid Assets: 42763.00
CGO balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 42763.00
CGO income_statement (annual, 2024-10-31) — Pretax Income: 35751085.00
CGO balance_sheet (annual, 2024-10-31) — Receivables: 1466932.00
CGO balance_sheet (quarterly, 2024-10-31) — Receivables: 1466932.00
CGO cash_flow (annual, 2024-10-31) — Repurchase Of Capital Stock: -4013334.00
CGO balance_sheet (annual, 2024-10-31) — Retained Earnings: 1147540.00
CGO balance_sheet (quarterly, 2024-10-31) — Retained Earnings: 1147540.00
CGO income_statement (annual, 2024-10-31) — Selling General And Administration: 217067.00
CGO balance_sheet (annual, 2024-10-31) — Share Issued: 9827294.00
CGO balance_sheet (quarterly, 2024-10-31) — Share Issued: 9827294.00
CGO balance_sheet (annual, 2024-10-31) — Stockholders Equity: 115917155.00
CGO balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 115917155.00
CGO balance_sheet (annual, 2024-10-31) — Tangible Book Value: 115917155.00
CGO balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 115917155.00
CGO income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
CGO income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.21
CGO balance_sheet (annual, 2024-10-31) — Total Assets: 179473766.00
CGO balance_sheet (quarterly, 2024-10-31) — Total Assets: 179473766.00
CGO balance_sheet (annual, 2024-10-31) — Total Capitalization: 164717155.00
CGO balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 164717155.00
CGO balance_sheet (annual, 2024-10-31) — Total Debt: 48800000.00
CGO balance_sheet (quarterly, 2024-10-31) — Total Debt: 48800000.00
CGO balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 115917155.00
CGO balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 115917155.00
CGO balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 63556611.00
CGO balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 63556611.00
CGO balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 2989604.00
CGO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 114769615.00
CGO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Federal Funds Sold: 12089050.00
CGO balance_sheet (quarterly, 2025-04-30) — Common Stock: 114769615.00
CGO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 107044715.00
CGO balance_sheet (quarterly, 2025-04-30) — Derivative Product Liabilities: 21018.00
CGO balance_sheet (quarterly, 2025-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 141060692.00
CGO balance_sheet (quarterly, 2025-04-30) — Invested Capital: 141835761.00
CGO balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 142617683.00
CGO balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 142617683.00
CGO balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 34791046.00
CGO balance_sheet (quarterly, 2025-04-30) — Net Debt: 34791046.00
CGO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 107044715.00
CGO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 9827294.00
CGO balance_sheet (quarterly, 2025-04-30) — Other Payable: 444191.00
CGO balance_sheet (quarterly, 2025-04-30) — Payables: 3433795.00
CGO balance_sheet (quarterly, 2025-04-30) — Preferred Securities Outside Stock Equity: 12945956.00
CGO balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 61045.00
CGO balance_sheet (quarterly, 2025-04-30) — Receivables: 3468752.00
CGO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -7724900.00
CGO balance_sheet (quarterly, 2025-04-30) — Share Issued: 9827294.00
CGO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 107044715.00
CGO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 107044715.00
CGO balance_sheet (quarterly, 2025-04-30) — Total Assets: 158301492.00
CGO balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 141835761.00
CGO balance_sheet (quarterly, 2025-04-30) — Total Debt: 34791046.00
CGO balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 107044715.00
CGO balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 51256777.00
CGO income_statement (annual, 2025-10-31) — +Operating Expense: 484207.00
CGO income_statement (annual, 2025-10-31) — +Total Revenue: 22842525.00
CGO balance_sheet (annual, 2025-10-31) — Accounts Payable: 1507434.00
CGO balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 1507434.00
CGO income_statement (annual, 2025-10-31) — Basic Average Shares: 9849479.00
CGO income_statement (annual, 2025-10-31) — Basic EPS: 2.27
CGO cash_flow (annual, 2025-10-31) — Beginning Cash Position: 6854402.00
CGO balance_sheet (annual, 2025-10-31) — Capital Stock: 114718923.00
CGO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 114718923.00
CGO balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 301491.00
CGO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 301491.00
CGO balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 3315187.00
CGO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 3315187.00
CGO cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -9434202.00
CGO balance_sheet (annual, 2025-10-31) — Cash Financial: 301491.00
CGO balance_sheet (quarterly, 2025-10-31) — Cash Financial: 301491.00
CGO cash_flow (annual, 2025-10-31) — Change In Other Current Assets: -12927.00
CGO cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: 0.00
CGO cash_flow (annual, 2025-10-31) — Change In Payable: -31293.00
CGO cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: -719.00
CGO cash_flow (annual, 2025-10-31) — Change In Receivables: 83429.00
CGO cash_flow (annual, 2025-10-31) — Change In Working Capital: 38490.00
CGO cash_flow (annual, 2025-10-31) — Changes In Cash: -3539215.00
CGO balance_sheet (annual, 2025-10-31) — Common Stock: 114718923.00
CGO balance_sheet (quarterly, 2025-10-31) — Common Stock: 114718923.00
CGO cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -9434202.00
CGO balance_sheet (annual, 2025-10-31) — Common Stock Equity: 128841271.00
CGO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 128841271.00
CGO cash_flow (annual, 2025-10-31) — Common Stock Issuance: 0.00
CGO balance_sheet (annual, 2025-10-31) — Derivative Product Liabilities: 15200.00
CGO balance_sheet (quarterly, 2025-10-31) — Derivative Product Liabilities: 15200.00
CGO income_statement (annual, 2025-10-31) — Diluted Average Shares: 9849479.00
CGO income_statement (annual, 2025-10-31) — Diluted EPS: 2.27
CGO income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 22358318.00
CGO cash_flow (annual, 2025-10-31) — End Cash Position: 3315187.00
CGO balance_sheet (annual, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 180059105.00
CGO balance_sheet (quarterly, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 180059105.00
CGO cash_flow (annual, 2025-10-31) — Financing Cash Flow: -14677420.00
CGO cash_flow (annual, 2025-10-31) — Free Cash Flow: 11138205.00
CGO cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: -11911056.00
CGO income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 10861416.00
CGO income_statement (annual, 2025-10-31) — General And Administrative Expense: 255956.00
CGO income_statement (annual, 2025-10-31) — Interest Expense: 2614132.00
CGO income_statement (annual, 2025-10-31) — Interest Income: 2110675.00
CGO balance_sheet (annual, 2025-10-31) — Invested Capital: 172441271.00
CGO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 172441271.00
CGO balance_sheet (annual, 2025-10-31) — Investmentin Financial Assets: 182759227.00
CGO balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 182759227.00
CGO balance_sheet (annual, 2025-10-31) — Investments And Advances: 182759227.00
CGO balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 182759227.00
CGO cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 2.00
CGO cash_flow (annual, 2025-10-31) — Issuance Of Debt: 9000000.00
CGO balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 43600000.00
CGO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 43600000.00
CGO cash_flow (annual, 2025-10-31) — Long Term Debt Issuance: 9000000.00
CGO cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -14200000.00
CGO cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: 0.00
CGO balance_sheet (annual, 2025-10-31) — Net Debt: 43298509.00
CGO balance_sheet (quarterly, 2025-10-31) — Net Debt: 43298509.00
CGO income_statement (annual, 2025-10-31) — Net Income: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 22358318.00
CGO cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 22358318.00
CGO income_statement (annual, 2025-10-31) — Net Interest Income: -503457.00
CGO cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -5200000.00
CGO cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -5200000.00
CGO cash_flow (annual, 2025-10-31) — Net Other Financing Charges: 0.00
CGO cash_flow (annual, 2025-10-31) — Net Preferred Stock Issuance: 2.00
CGO balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 128841271.00
CGO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 128841271.00
CGO income_statement (annual, 2025-10-31) — Normalized Income: 22358318.00
CGO cash_flow (annual, 2025-10-31) — Operating Cash Flow: 11138205.00
CGO income_statement (annual, 2025-10-31) — Operating Revenue: 22842525.00
CGO balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 9827294.00
CGO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 9827294.00
CGO cash_flow (annual, 2025-10-31) — Other Non Cash Items: 652453.00
CGO income_statement (annual, 2025-10-31) — Other Operating Expenses: 228251.00
CGO balance_sheet (annual, 2025-10-31) — Other Payable: 531757.00